DMH4
Chemical Name: 6-[4-[2-(4-Morpholinyl)ethoxy]phenyl]-3-phenylpyrazolo[1,5-a]pyrimidine
Purity: ≥98%
Biological Activity
DMH4 is a selective VEGFR-2 inhibitor (IC50 values are 161, 3558, 8038 and > 30000 nM for VEGFR-2, BMPR-I, AMPK and TGFβR-I respectively). Displays antiangiogenic activity in vitro and in vivo.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics.
Fraley et al.
Bioorg.Med.Chem.Lett., 2002;12:3537 -
In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors.
Hao et al.
ACS Chem.Biol., 2010;5:245
Product Datasheets
Reconstitution Calculator
Molarity Calculator
Citation for DMH4
The citations listed below are publications that use Tocris products. Selected citations for DMH4 include:
1 Citation: Showing 1 - 1
-
Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis.
Authors: Lee Et al.
J Clin Invest 2017;127:457
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for DMH4
There are currently no reviews for this product. Be the first to review DMH4 and earn rewards!
Have you used DMH4?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
